IMMU - Immunomedics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Immunomedics's activity chart (see below) currently has 94 price targets and 75 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 95.45% with an average time for these price targets to be met of 188.36 days.

Most recent stock forecast was given by from JEFFERIES on 15-Sep-2020. First documented stock forecast 29-Jul-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Oct-2016

$55

6 years 1 months 10 days ago
(15-Sep-2020)

5/5 (100%)

$11.69 (26.99%)

126

Buy Since 04-Mar-2019

$56

6 years 1 months 11 days ago
(14-Sep-2020)

9/9 (100%)

$14.84 (36.05%)

173

Buy Since 06-Jul-2020

$55

6 years 1 months 11 days ago
(14-Sep-2020)

5/5 (100%)

$14.37 (35.37%)

185

$40

$-47.86 (-54.47%)

$19

6 years 2 months 15 days ago
(10-Aug-2020)

5/5 (100%)

$-0.92 (-2.25%)

350

Buy Since 17-Sep-2018

$55

$-32.86 (-37.40%)

$52

6 years 2 months 19 days ago
(06-Aug-2020)

5/5 (100%)

$11.82 (27.37%)

173

Show more analysts

Please expand the browser size to see the chart

What is IMMU (Immunomedics) average time for price targets to be met?

On average it took 188 days for the stock forecasts to be reached, with an average price target met ratio of 95.45%.

Which analyst most recently updated their price target on IMMU (Immunomedics)?

Which analyst has the most public recommendations on IMMU (Immunomedics)?

has 0 price targets and 0 ratings on IMMU

Which analyst is the currently most bullish on IMMU (Immunomedics)?

Raghuram Selvaraju with the highest potential upside of $0

Which analyst is the currently most reserved on IMMU (Immunomedics)?

Matthew Andrews with the lowest potential downside of -$65.86
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?